Protagen, NCI Partner to Identify Cancer Immunotherapy Biomarkers – GenomeWeb
|
Protagen, NCI Partner to Identify Cancer Immunotherapy Biomarkers
GenomeWeb Under the terms of their material transfer agreement, the collaborators will use Protagen's SeroTag platform — which measures autoantibody levels for thousands of antigens simultaneously — to identify biomarkers that predict immunotherapy … |
